Role of pertuzumab in the treatment of HER2-positive breast cancer
Michael Hubalek, Christine Brantner, Christian MarthBrustgesundheitzentrum Tirol, Department of Obstetrics and Gynecology, Innsbruck Medical University, Innsbruck, AustriaAbstract: Pertuzumab, a humanized monoclonal antibody to the HER2 receptor, represents a promising new anti-HER2 agent with a nov...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2012-05-01
|
| Series: | Breast Cancer : Targets and Therapy |
| Online Access: | http://www.dovepress.com/role-of-pertuzumab-in-the-treatment-of-her2-positive-breast-cancer-a9978 |